Associate Professor Belamy Cheung

Program Manager and Principal Scientist, Children’s Cancer institute

Assoc. Professor Belamy Cheung was awarded $172, 000 in 2023 for her research project, starting in 2024. This innovative research will be jointly funded by Neuroblastoma Australia and Kids’ Cancer Project.

Assoc. Prof. Cheung’s research will investigate a combined treatment targeting the MYNC gene, which has been identified for some time as a key driver of tumour growth.

In the proposed project Assoc. Prof. Cheung’s team aim to further improve the efficacy of this combination therapy, so they can rapidly translate these findings to the clinic and directly benefit children with high-risk and relapsed neuroblastoma.

One third of childhood cancer survivors have a major health problem in young adulthood, and there is an urgent need for new drugs with high specificity for cancer cells and low toxicity for the normal growing tissues of a child. Assoc. Prof. Belamy Cheung

Enable this content?

This content is served by a third party, www.youtube.com. If enabled, www.youtube.com may collect information about your activity. Manage preferences to always allow this content.PreferencesEnable

More information

Dr. Belamy Cheung

Donate to fund reserach

Neuroblastoma Australia has raised over $4 million for innovative research, funding 17 early stage projectsfocused on changing the future for children with neuroblastoma – one of the most aggressive childhood cancers. Behind every dollar raised are children and families facing the devastating impact of this disease, like the story shared here.

Donate now to help fund potentially life-changing medical research that gives hope to children diagnosed with neuroblastoma. Donations are secure and you’ll receive an immediate tax-deductible receipt. Thank you.